THE CONTRIBUTION OF GENETICALLY-DETERMINED OXIDATION STATUS TO INTERINDIVIDUAL VARIATION IN PHENACETIN DISPOSITION

被引：35

作者：

DEVONSHIRE, HW

KONG, I

COOPER, M

SLOAN, TP

IDLE, JR

SMITH, RL

机构：

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1983年 / 16卷 / 02期

关键词：

D O I：

10.1111/j.1365-2125.1983.tb04980.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：157 / 166

页数：10

共 32 条

[1] MIGRAINE AS A DEADLY DISEASE [J].

ASKUPMARK, E .

BRITISH MEDICAL JOURNAL, 1960, 2 (SEP17) :823-825

[2] PHARMACOGENETIC COVARIATION OF DEFECTIVE N-OXIDATION OF SPARTEINE AND 4-HYDROXYLATION OF DEBRISOQUINE [J].

BERTILSSON, L ;

DENGLER, HJ ;

EICHELBAUM, M ;

SCHULZ, HU .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (02) :153-155

[3]

BRODIE BB, 1949, J PHARMACOL EXP THER, V97, P58

[4] METABOLISCHE UNWANDLUNG VON PHENACETIN UND N-ACETYL-P-AMINOPHENOL NACH VORBEHANDLUNG MIT PHENOBARBITAL [J].

BUCH, H ;

GERHARDS, W ;

PFLEGER, K ;

RUDIGER, W ;

RUMMEL, W .

BIOCHEMICAL PHARMACOLOGY, 1967, 16 (08) :1585-&

[5] HEMMUNG DER DURCH PHENACETIN UND P-PHENETIDIN VERURSACHTEN METHAMOGLOBIN-BILDUNG DURCH BARBITURATE [J].

BUCH, H ;

GERHARDS, W ;

KARACHRI.G ;

PFLEGER, K ;

RUMMEL, W .

BIOCHEMICAL PHARMACOLOGY, 1967, 16 (08) :1575-&

[6]

CONNEY AH, 1976, CLIN PHARMACOL THER, V20, P633

[7]

CONNEY AH, 1974, CHEMICAL CARCINOGENE, P3

[8] KINETIC CONSIDERATIONS RELATING TO ACCRUAL AND ELIMINATION OF DRUG METABOLITES [J].

CUMMINGS, AJ ;

MARTIN, BK ;

PARK, GS .

BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1967, 29 (02) :136-&

[9] A KINETIC STUDY OF DRUG ELIMINATION - EXCRETION OF PARACETAMOL AND ITS METABOLITES IN MAN [J].

CUMMINGS, AJ ;

KING, ML ;

MARTIN, BK .

BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1967, 29 (02) :150-&

[10] EVIDENCE FOR AN ENZYMATIC DEFECT IN THE 4-HYDROXYLATION OF DEBRISOQUINE BY HUMAN-LIVER [J].

DAVIES, DS ;

KAHN, GC ;

MURRAY, S ;

BRODIE, MJ ;

BOOBIS, AR .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (01) :89-91

← 1 2 3 4 →